FIL Ltd - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FIL Ltd ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$406,000
-4.2%
83,1910.0%0.00%
Q1 2021$424,000
+21100.0%
83,191
+17267.6%
0.00%
Q4 2020$2,000
-71.4%
479
+60.2%
0.00%
Q3 2020$7,0002990.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders